Archives of Pharmacal Research

, Volume 41, Issue 2, pp 243–250 | Cite as

Anti-inflammatory effects of sinapic acid on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice

  • Ji-Yun Lee
Research Article


This study was conducted to evaluate the effect of sinapic acid, a cinnamic acid derivative, on inflammatory changes in a mouse model of colitis. Colitis was induced by intracolonic instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS). Sinapic acid (10, 30, and 100 mg/kg) and dexamethasone (2 mg/kg) were orally administered to Balb/c female mice after TNBS instillation. The anti-inflammatory effect of sinapic acid on colonic injury or damage was assessed by clinical, macroscopic, microscopic, and biochemical analyses. Compared with TNBS control, treatment with sinapic acid significantly improved colonic weight and length and decreased the macroscopic and microscopic changes in TNBS-induced colitis. Furthermore, myeloperoxidase activity and the colonic tissue levels of malondialdehyde and tumor necrosis factor alpha were decreased by administration of sinapic acid. The findings of this study suggest that sinapic acid exerts anti-inflammatory effects on intestinal inflammation and can be selected as a novel therapeutic candidate in the treatment of inflammatory bowel disease.


Sinapic acid 2,4,6-Trinitrobenzenesulfonic acid Colitis Myeloperoxidase Malondialdehyde TNF-α 



This research was supported by the Chung-Ang University Research Grants in 2015.

Compliance with ethical standards

Conflict of interest

The author declares no conflict of interest.


  1. Chachu KA, Osterman MT (2016) How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD. Inflamm Bowel Dis 22:1262–1274CrossRefPubMedGoogle Scholar
  2. Chen C (2016) Sinapic acid and its derivates as medicine in oxidative stress-induced diseases and aging. Oxid Med Cell Longev. Google Scholar
  3. Cuvelier ME, Richard H, Berset C (1992) Comparison of the antioxidative activity of some acid-phenols—structure–activity relationship. Biosci Biotechnol Biochem 56:324–325CrossRefGoogle Scholar
  4. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463CrossRefPubMedPubMedCentralGoogle Scholar
  5. Duvnjak M, Bilic A, Barsic N, Tomasic V, Stojsavljevic S (2013) Classical medications in the treatment of inflammatory bowel diseases. Acta Med Croatica 67:11–124Google Scholar
  6. Fukuda W, Takagi T, Katada K, Mizushima K, Okayama T, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Handa O, Konishi H, Yagi N, Ichikawa H, Yoshikawa T, Cepinskas G, Naito Y, Itoh Y (2014) Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice. Dig Dis Sci 59:1142–1151CrossRefPubMedGoogle Scholar
  7. Galano A, Francisco-Marquez M, Alvarez-Idaboy JR (2011) Mechanism and kinetics studies on the antioxidant activity of sinapinic acid. Phys Chem Chem Phys 13:11199–11205CrossRefPubMedGoogle Scholar
  8. Gan XL, Hei ZQ, Huang HQ, Chen LX, Li SR, Cai J (2006) Effect of Astragalus membranaceus injection on the activity of the intestinal mucosal mast cells after hemorrhagic shock-reperfusion in rats. Chin Med J (Engl) 119:1892–1898Google Scholar
  9. Hooper KM, Barlow PG, Stevens C, Henderson P (2017) Inflammatory bowel disease drugs: a focus on autophagy. J Crohns Colitis 11:118–127CrossRefPubMedGoogle Scholar
  10. Jia Y, Guan Q, Jiang Y, Salh B, Guo Y, Tu P, Du C (2014) Amelioration of dextran sulphate sodium-induced colitis in mice by echinacoside-enriched extract of Cistanche tubulosa. Phytother Res 28:110–119CrossRefPubMedGoogle Scholar
  11. Katz LH, Kopylov U, Fudim E, Yavzori M, Picard O, Ungar B, Eliakim R, Ben-Horin S, Chowers Y (2014) Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn’s disease treated with anti-TNF antibodies. Clin Res Hepatol Gastroenterol 38:491–498CrossRefPubMedGoogle Scholar
  12. Kim DH, Yoon BH, Jung WY, Kim JM, Park SJ, Park DH, Huh Y, Park C, Cheong JH, Lee KT, Shin CY, Ryu JH (2010) Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 59:20–30CrossRefPubMedGoogle Scholar
  13. Liu X, Wang J (2011) Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J Ethnopharmacol 133:780–787CrossRefPubMedGoogle Scholar
  14. Luceri C, Guglielmi F, Lodovici M, Giannini L, Messerini L, Dolara P (2004) Plant phenolic 4-coumaric acid protects against intestinal inflammation in rats. Scand J Gastroenterol 39:1128–1133PubMedGoogle Scholar
  15. Menchen LA, Colon AL, Moro MA, Leza JC, Lizasoain I, Menchen P, Alvarez E, Lorenzo P (2001) N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 69:479–491CrossRefPubMedGoogle Scholar
  16. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803CrossRefPubMedGoogle Scholar
  17. Niwa T, Doi U, Kato Y, Osawa T (1999) Inhibitory mechanism of sinapinic acid against peroxynitrite-mediated tyrosine nitration of protein in vitro. FEBS Lett 459:43–46CrossRefPubMedGoogle Scholar
  18. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefPubMedGoogle Scholar
  19. Park SY, Neupane GP, Lee SO, Lee JS, Kim MY, Kim SY, Park YJ, Kim JA (2014) Protective effects of Pogostemon cabin Bentham water extraction on inflammatory cytokine expression in TNBS-induced colitis in rats. Arch Pharm Res 37:253–262CrossRefPubMedGoogle Scholar
  20. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429CrossRefPubMedGoogle Scholar
  21. Sadar SS, Vyawahare NS, Bodhankar SL (2016) Ferulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, oxidative stress, iNOS, COX-2, and apoptosis in laboratory rats. EXCLI J 15:482–499PubMedPubMedCentralGoogle Scholar
  22. Sartor RB, Cromartie WJ, Powell DW, Schwab JH (1985) Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 89:587–595CrossRefPubMedGoogle Scholar
  23. Van Meeteren ME, Meijssen MA, Zijlstra FJ (2000) The effect of dexamethasone treatment on murine colitis. Scand J Gastroenterol 35:517–521CrossRefPubMedGoogle Scholar
  24. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E (2002) Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 47:1447–1457CrossRefPubMedGoogle Scholar
  25. Wallace JL (1988) Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol 66:422–425CrossRefPubMedGoogle Scholar
  26. Wang YH, Dong J, Zhang JX, Zhai J, Ge B (2016) Effects of mimic of manganese superoxide dismutase on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Arch Pharm Res 39:1296–1306CrossRefPubMedGoogle Scholar
  27. Zaotrski H, Sałaga M, Zielińska M, Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C, Fichna J (2015) Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn Schmiedebergs Arch Pharmacol 388:643–651CrossRefGoogle Scholar
  28. Zhang Z, Wu X, Cao S, Wang L, Wang D, Yang H, Feng Y, Wang S, Li L (2016) Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget 7:31790–31799PubMedPubMedCentralGoogle Scholar
  29. Zou Y, Dai SX, Chi HG, Li T, He ZW, Wang J, Ye CG, Huang GL, Zhao B, Li WY, Wan Z, Feng JS, Zheng XB (2015) Baicalin attenuates TNBS-induced colitis in rats by modulating the Th1/Treg paradigm. Arch Pharm Res 38:1873–1887CrossRefPubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2018

Authors and Affiliations

  1. 1.College of PharmacyChung-Ang UniversitySeoulRepublic of Korea

Personalised recommendations